Pharmacometabolomics of Andrographis Paniculata And Metformin In Healthy Volunteers Under Fasting Condition
Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
This study is a phase 1, open label, randomized, three-way crossover, single dose, oral-
administration of Andrographis paniculata and Metformin in healthy volunteers under fasting
condition. The study will demonstrate the pharmacokinetics profile and pharmacodynamic
through metabolic pathway analysis for Andrographis paniculata and Metformin.
Phase:
Phase 1
Details
Lead Sponsor:
University of Malaya
Collaborators:
Ministry of Health, Malaysia National Pharmaceutical Regulatory Agency